HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
701	15791 Neumann M, Mittelbronn M, Simon P, Vanmassenhove B, de Silva R, et al. A New family with frontotemporal dementia with intronic 10+3 splice site mutation in the tau gene: neuropathology and molecular effects NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2005 AUG; 31 (4): 362-373	6	7	48	51
702	15945 Kaul S, Anantharam V, Kanthasamy A, Kanthasamy AG Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKC delta and BAD to protect dopaminergic neuronal cells against MPP+- induced apoptotic cell death MOLECULAR BRAIN RESEARCH. 2005 SEP 13; 139 (1): 137-152	15	6	48	103
703	17182 Avila J Tau phosphorylation and aggregation in Alzheimer's disease pathology FEBS LETTERS. 2006 MAY 22; 580 (12): 2922-2927	41	63	48	82
704	17481 Reddy PH, McWeeney S Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models NEUROBIOLOGY OF AGING. 2006 AUG; 27 (8): 1060-1077	8	24	48	162
705	17850 Ozawa T Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum ACTA NEUROPATHOLOGICA. 2006 NOV; 112 (5): 531-538	3	6	48	101
706	18317 O'Neill MJ, Messenger MJ, Lakics V, Murray TK, Karran EH, et al. Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease PHARMACOLOGY OF NEUROGENESIS AND NEUROENHANCEMENT. 2007; 77: 179-+	1	5	48	243
707	18355 Eriksen JL, Janus CG Plaques, tangles, and memory loss in mouse models of neurodegeneration BEHAVIOR GENETICS. 2007 JAN; 37 (1): 79-100	12	36	48	228
708	20020 Frasier M, Frausto S, Lewicki D, Golbe L, Wolozin B Dissecting the biochemical pathways mediated by genes implicated in Parkinson's disease: Induction of DJ-1 expression in A30P alpha- synuclein mice ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 97-112	0	0	48	66
709	21225 Mizuno Y, Hattori N, Kubo SI, Sato S, Nishioka K, et al. Progress in the pathogenesis and genetics of Parkinson's disease PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2008 JUN 27; 363 (1500): 2215-2227	5	14	48	178
710	21901 Vali S, Chinta SJ, Peng J, Sultana Z, Singh N, et al. Insights into the effects of alpha-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture data FREE RADICAL BIOLOGY AND MEDICINE. 2008 NOV 1; 45 (9): 1290-1301	2	3	48	85
#	Date / Author / Journal	LCS	GCS	LCR	CR
711	22206 Mandelkow EM, Thies E, Konzack S, Mandelkow E Tau and Intracellular Transport in Neurons INTRACELLULAR TRAFFIC AND NEURODEGENERATIVE DISORDERS. 2009; : 59-70	0	0	48	64
712	22234 Gotz J, Schonrock N, Vissel B, Ittner LM Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice JOURNAL OF ALZHEIMERS DISEASE. 2009; 18 (2): 243-251	1	5	48	92
713	22745 Wolfe MS Tau Mutations in Neurodegenerative Diseases JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAR 6; 284 (10): 6021-6025	7	11	48	61
714	23111 Ubhi K, Rockenstein E, Doppler E, Mante M, Adame A, et al. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin ACTA NEUROPATHOLOGICA. 2009 JUN; 117 (6): 699-712	0	4	48	88
715	23888 Waxman EA, Mazzulli JR, Giasson BI Characterization of Hydrophobic Residue Requirements for alpha- Synuclein Fibrillization BIOCHEMISTRY. 2009 OCT 13; 48 (40): 9427-9436	4	4	48	62
716	24773 Lewis KA, Yaeger A, DeMartino GN, Thomas PJ Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations JOURNAL OF BIOENERGETICS AND BIOMEMBRANES. 2010 FEB; 42 (1): 85-95	1	1	48	71
717	25105 Kim EK, Choi EJ Pathological roles of MAPK signaling pathways in human diseases BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 APR; 1802 (4): 396-405	0	22	48	176
718	25673 Zuccato C, Valenza M, Cattaneo E Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease PHYSIOLOGICAL REVIEWS. 2010 JUL; 90 (3): 905-981	0	8	48	673
719	25775 Peviani M, Caron I, Pizzasegola C, Gensano F, Tortarolo M, et al. Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 AUG; 9 (4): 491-503	0	0	48	158
720	25885 Iijima K, Gatt A, Iijima-Ando K Tau Ser262 phosphorylation is critical for A beta 42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease HUMAN MOLECULAR GENETICS. 2010 AUG 1; 19 (15): 2947-2957	1	1	48	116
#	Date / Author / Journal	LCS	GCS	LCR	CR
721	26163 Nyhlen J, Constantinescu R, Zetterberg H Problems associated with fluid biomarkers for Parkinson's disease BIOMARKERS IN MEDICINE. 2010 OCT; 4 (5): 671-681	1	1	48	121
722	26305 Roodveldt C, Labrador-Garrido A, Gonzalez-Rey E, Fernandez-Montesinos R, Caro M, et al. Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants PLOS ONE. 2010 OCT 26; 5 (10): Art. No. e13481	0	0	48	85
723	26408 Jucker M The benefits and limitations of animal models for translational research in neurodegenerative diseases NATURE MEDICINE. 2010 NOV; 16 (11): 1210-1214	2	5	48	106
724	26880 Jellinger KA, Grazer A, Petrovic K, Ropele S, Alpi G, et al. Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration? ACTA NEUROPATHOLOGICA. 2011 FEB; 121 (2): 267-277	0	0	48	75
725	5226 Tranchant C Tau proteins and neurodegenerative diseases M S-MEDECINE SCIENCES. 1997 AUG-SEP; 13 (8-9): 989-997	1	6	47	69
726	5612 Shea TB, Ekinci FJ Influence of phospholipids and sequential kinase activities on tau in vitro MOLECULAR AND CELLULAR MECHANISMS OF NEURONAL PLASTICITY. 1998; 446: 181-201	0	2	47	84
727	7846 Spillantini MG, Goedert M The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy MOLECULAR BASIS OF DEMENTIA. 2000; 920: 16-27	86	103	47	82
728	8790 Ksiezak-Reding H, He DK, Gordon-Krajcer W, Kress Y, Lee S, et al. Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes CELL MOTILITY AND THE CYTOSKELETON. 2000 NOV; 47 (3): 236-252	8	16	47	89
729	9393 Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, et al. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration BRAIN PATHOLOGY. 2001 APR; 11 (2): 144-158	48	103	47	90
730	10866 Mehta PD, Pirttila T Biological markers of Alzheimer's disease DRUG DEVELOPMENT RESEARCH. 2002 JUN; 56 (2): 74-84	3	6	47	115
#	Date / Author / Journal	LCS	GCS	LCR	CR
731	11783 Kesavapany S, Li BS, Pant HC Cyclin-dependent kinase 5 in neurofilament function and regulation NEUROSIGNALS. 2003; 12 (4-5): 252-264	6	21	47	87
732	12830 Andreasen N, Sjogren M, Blennow K CSF markers for Alzheimer's disease: Total Tau, phospho-tau and A beta 42 WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2003 OCT; 4 (4): 147-155	18	42	47	81
733	12851 Hegde ML, Rao KSJ Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2003 OCT 15; 418 (2): 169-178	7	8	47	78
734	13497 Krishnamurthy PK, Johnson GVW Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 FEB 27; 279 (9): 7893-7900	18	20	47	61
735	14756 Casetta I, Govoni V, Granieri E Oxidative stress, antioxidants and neurodegenerative diseases CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (16): 2033-2052	3	40	47	366
736	14817 Liu YY, Yang H Environmental toxins and alpha-synuclein in Parkinson's disease MOLECULAR NEUROBIOLOGY. 2005; 31 (1-3): 273-282	1	3	47	68
737	14850 Pountney DL, Voelcker NH, Gai WP Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis. NEUROTOXICITY RESEARCH. 2005; 7 (1-2): 59-67	11	16	47	62
738	14956 Hyman BT, Augustinack JC, Ingelsson M Transcriptional and conformational changes of the tau molecule in Alzheimer's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 150-157	15	17	47	73
739	15086 Newman MB, Misiuta I, Willing AE, Zigova T, Karl RC, et al. Tumorigenicity issues of embryonic carcinoma-derived stem cells: Relevance to surgical trials using NT2 and hNT neural cells STEM CELLS AND DEVELOPMENT. 2005 FEB; 14 (1): 29-43	11	26	47	125
740	16067 Utton MA, Noble WJ, Hill JE, Anderton BH, Hanger DP Molecular motors implicated in the axonal transport of tau and alpha- synuclein JOURNAL OF CELL SCIENCE. 2005 OCT 15; 118 (20): 4645-4654	24	30	47	76
#	Date / Author / Journal	LCS	GCS	LCR	CR
741	16174 Imbimbo BP, Lombard J, Pomara N Pathophysiology of Alzheimer's disease NEUROIMAGING CLINICS OF NORTH AMERICA. 2005 NOV; 15 (4): 727-+	3	7	47	258
742	18751 Yu S, Li X, Liu G, Han J, Zhang C, et al. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody NEUROSCIENCE. 2007 MAR 16; 145 (2): 539-555	24	28	47	59
743	19615 Boxer AL, Boeve BF Frontotemporal dementia treatment: Current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S79-S87	13	15	47	106
744	19663 Monti B, Polazzi E, Batti L, Crochemore C, Virgili M, et al. Alpha-synuclein protects cerebellar granule neurons against 6- hydroxydopamine-induced death JOURNAL OF NEUROCHEMISTRY. 2007 OCT; 103 (2): 518-530	10	17	47	82
745	19751 Eckermann K, Mocanu MM, Khlistunova I, Biernat J, Nissen A, et al. The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 OCT 26; 282 (43): 31755-31765	20	27	47	65
746	20526 Mondragon-Rodriguez S, Mena R, Binder LI, Smith MA, Perry G, et al. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2008 FEB; 34 (1): 62-75	5	6	47	74
747	20553 Rott R, Szargel R, Haskin J, Shani V, Shainskaya A, et al. Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 FEB 8; 283 (6): 3316-3328	19	25	47	74
748	20630 Jellinger KA, Attems J Cerebral amyloid angiopathy in Lewy body disease JOURNAL OF NEURAL TRANSMISSION. 2008 MAR; 115 (3): 473-482	1	6	47	92
749	21231 Kovacs GG, Pittman A, Revesz T, Luk C, Lees A, et al. MAPT S305I mutation: implications for argyrophilic grain disease ACTA NEUROPATHOLOGICA. 2008 JUL; 116 (1): 103-118	4	4	47	65
750	21469 Deierborg T, Soulet D, Roybon L, Hall V, Brundin P Emerging restorative treatments for Parkinson's disease PROGRESS IN NEUROBIOLOGY. 2008 AUG; 85 (4): 407-432	9	38	47	300
#	Date / Author / Journal	LCS	GCS	LCR	CR
751	21865 Ko LW, Ko HHC, Lin WL, Kulathingal JG, Yen SHC Aggregates Assembled From Overexpression of Wild-Type alpha-Synuclein are not Toxic to Human Neuronal Cells JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 NOV; 67 (11): 1084-1096	5	6	47	66
752	21899 Wang IF, Wu LS, Shen CKJ TDP-43: an emerging new player in neurodegenerative diseases TRENDS IN MOLECULAR MEDICINE. 2008 NOV; 14 (11): 479-485	20	22	47	87
753	21929 Nakamura K, Nemani VM, Wallender EK, Kaehlcke K, Ott M, et al. Optical Reporters for the Conformation of alpha-Synuclein Reveal a Specific Interaction with Mitochondria JOURNAL OF NEUROSCIENCE. 2008 NOV 19; 28 (47): 12305-12317	12	16	47	96
754	22409 Han D, Paudel HK FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract NEUROCHEMISTRY INTERNATIONAL. 2009 JAN; 54 (1): 14-27	1	1	47	63
755	22678 Castellani RJ, Zhu XW, Lee HG, Smith MA, Perry G Molecular Pathogenesis of Alzheimer's Disease: Reductionist versus Expansionist Approaches INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1386-1406	5	12	47	146
756	22789 Yokota O, Tsuchiya K, Arai T, Yagishita S, Matsubara O, et al. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions ACTA NEUROPATHOLOGICA. 2009 APR; 117 (4): 429-444	6	6	47	74
757	22827 Vucic S, Kiernan MC Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis CURRENT MOLECULAR MEDICINE. 2009 APR; 9 (3): 255-272	5	20	47	292
758	23924 Bulat N, Widmann C Caspase substrates and neurodegenerative diseases BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 251-267	1	3	47	205
759	23963 Ardley HC Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases CURRENT PHARMACEUTICAL DESIGN. 2009 NOV; 15 (31): 3697-3715	0	5	47	303
760	24321 Shah A, Garzon-Muvdi T, Mahajan R, Duenas VJ, Quinones-Hinojosa A Animal Models of Neurological Disease FRONTIERS IN BRAIN REPAIR. 2010; 671: 23-40	0	0	47	132
#	Date / Author / Journal	LCS	GCS	LCR	CR
761	24466 Fortin DL, Nemani VM, Nakamura K, Edwards RH The Behavior of alpha-Synuclein in Neurons MOVEMENT DISORDERS. 2010; 25 (3): S21-S26	2	2	47	74
762	24628 Arvanitakis Z Update on Frontotemporal Dementia NEUROLOGIST. 2010 JAN; 16 (1): 16-22	2	2	47	74
763	24679 Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, et al. Increased Expression of alpha-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis NEURON. 2010 JAN 14; 65 (1): 66-79	18	25	47	74
764	25040 Paleologou KE, Oueslati A, Shakked G, Rospigliosi CC, Kim HY, et al. Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits alpha-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions JOURNAL OF NEUROSCIENCE. 2010 MAR 3; 30 (9): 3184-3198	7	7	47	67
765	26335 Huang QA, Figueiredo-Pereira ME Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications APOPTOSIS. 2010 NOV; 15 (11): 1292-1311	0	2	47	217
766	26538 Costa J, Gomes C, de Carvalho M Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 764-778	1	1	47	232
767	3438 SHIN RW, Lee VMY, Trojanowski JQ ALUMINUM MODIFIES THE PROPERTIES OF ALZHEIMERS-DISEASE PHF-TAU PROTEINS IN-VIVO AND IN-VITRO JOURNAL OF NEUROSCIENCE. 1994 NOV; 14 (11): 7221-7233	76	76	46	99
768	8211 Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3 beta JOURNAL OF NEUROCHEMISTRY. 2000 APR; 74 (4): 1587-1595	95	169	46	66
769	9567 Sayre LM, Smith MA, Perry G Chemistry and biochemistry of oxidative stress in neurodegenerative disease CURRENT MEDICINAL CHEMISTRY. 2001 JUN; 8 (7): 721-738	58	234	46	232
770	10300 Spillantini MG, Tofaris GK Molecular biology of Lewy body formation - alpha-Synudeinopathies MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 483-489	0	0	46	68
#	Date / Author / Journal	LCS	GCS	LCR	CR
771	12350 Davis S, Laroche S What can rodent models tell us about cognitive decline in Alzheimer's disease? MOLECULAR NEUROBIOLOGY. 2003 JUN; 27 (3): 249-276	5	11	46	240
772	12983 Necula M, Chirita CN, Kuret J Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 NOV 21; 278 (47): 46674-46680	40	74	46	80
773	13455 Baptista MJ, Cookson MR, Miller DW Parkin and alpha-synuclein: Opponent actions in the pathogenesis of Parkinson's disease NEUROSCIENTIST. 2004 FEB; 10 (1): 63-72	2	5	46	61
774	13633 Emadi S, Liu RT, Yuan B, Schulz P, McAllister C, et al. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments BIOCHEMISTRY. 2004 MAR 16; 43 (10): 2871-2878	28	47	46	71
775	14629 Ko LW, Rush T, Sahara N, Kersh JS, Easson C, et al. Assembly of filamentous tau aggregates in human neuronal cells JOURNAL OF ALZHEIMERS DISEASE. 2004 DEC; 6 (6): 605-622	12	14	46	58
776	14713 Hoyer W, Cherny D, Subramaniam V, Jovin TM Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro BIOCHEMISTRY. 2004 DEC 28; 43 (51): 16233-16242	49	64	46	57
777	14727 Bilen J, Bonini NM Drosophila as a model for human neurodegenerative disease ANNUAL REVIEW OF GENETICS. 2005; 39: 153-171	37	111	46	106
778	14986 Zhou ZD, Yap BP, Gung AYT, Leong SM, Ang ST, et al. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha- synuclein EXPERIMENTAL CELL RESEARCH. 2005 JAN 15; 312 (2): 156-170	1	1	46	59
779	15556 Armstrong RA, Lantos PL, Cairns NJ Overlap between neurodegenerative disorders NEUROPATHOLOGY. 2005 JUN; 25 (2): 111-124	8	22	46	150
780	15930 Hoffner G, Djian P Transglutaminase and diseases of the central nervous system FRONTIERS IN BIOSCIENCE. 2005 SEP 1; 10: 3078-3092	1	12	46	134
#	Date / Author / Journal	LCS	GCS	LCR	CR
781	16399 Stokin GB, Goldstein LSB Axonal transport and Alzheimer's disease ANNUAL REVIEW OF BIOCHEMISTRY. 2006; 75: 607-627	22	64	46	181
782	16804 Yoshida H, Craxton M, Jakes R, Zibaee S, Tavare R, et al. Synuclein proteins of the pufferfish Fugu rubripes: Sequences and functional characterization BIOCHEMISTRY. 2006 FEB 28; 45 (8): 2599-2607	11	11	46	66
783	17015 Saido TC, Iwata N Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease - Towards presymptomatic diagnosis, prevention and therapy NEUROSCIENCE RESEARCH. 2006 APR; 54 (4): 235-253	17	49	46	171
784	17039 von Coelln R, Thomas B, Andrabi SA, Lim KL, Savitt JM, et al. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy JOURNAL OF NEUROSCIENCE. 2006 APR 5; 26 (14): 3685-3696	21	28	46	59
785	17493 Shiarli AM, Jennings R, Shi J, Bailey K, Davidson Y, et al. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2006 AUG; 32 (4): 374-387	10	11	46	60
786	17749 Yoshida H, Goedert M Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38 delta or JNK2 in the presence of heparin generates the AT100 epitope JOURNAL OF NEUROCHEMISTRY. 2006 OCT; 99 (1): 154-164	12	16	46	64
787	18199 de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease IMAGING AND THE AGING BRAIN. 2007; 1097: 114-145	22	55	46	165
788	19044 Mandemakers W, Morais VA, De Strooper B A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases JOURNAL OF CELL SCIENCE. 2007 MAY 15; 120 (10): 1707-1716	10	52	46	151
789	19365 Klein C, Lohmann-Hedrich K Impact of recent genetic findings in Parkinson's disease CURRENT OPINION IN NEUROLOGY. 2007 AUG; 20 (4): 453-464	16	39	46	172
790	19437 Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, et al. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 AUG 10; 282 (32): 23645-23654	40	61	46	75
#	Date / Author / Journal	LCS	GCS	LCR	CR
791	19881 Klein C, Schlossmacher MG Parkinson disease, 10 years after its genetic revolution - Multiple clues to a complex disorder NEUROLOGY. 2007 NOV 27; 69 (22): 2093-2104	19	55	46	144
792	20135 Pei JJ, Bjorkdahl C, Zhang HY, Zhou XW, Winblad B p70 S6 kinase and tau in Alzheimer's disease JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 385-392	0	1	46	94
793	20483 Schindowski K, Belarbi K, Buee L Neurotrophic factors in Alzheimer's disease: role of axonal transport GENES BRAIN AND BEHAVIOR. 2008 FEB; 7: 43-56	10	46	46	199
794	20817 Mendez MF, Lauterbach EC, Sampson SM, ANPA Comm Res An evidence-based review of the psychopathology of frontotemporal dementia: A report of the ANPA Committee on Research JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2008 SPR; 20 (2): 130-149	5	14	46	191
795	20947 Waxman EA, Giasson BI Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 MAY; 67 (5): 402-416	17	19	46	64
796	21284 Shaikh S, Nicholson LFB Advanced glycation end products induce in vitro cross-linking of alpha- synuclein and accelerate the process of intracellular inclusion body formation JOURNAL OF NEUROSCIENCE RESEARCH. 2008 JUL; 86 (9): 2071-2082	5	9	46	77
797	21524 Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG Multiple system atrophy: A primary oligodendrogliopathy ANNALS OF NEUROLOGY. 2008 SEP; 64 (3): 239-246	20	30	46	93
798	21671 Abdel-Salam OME Drugs Used to Treat Parkinson's Disease, Present Status and Future Directions CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 OCT; 7 (4): 321-342	2	6	46	331
799	22052 Toribio-Diaz ME, Morera-Guitart J CLINICAL AND BIOMOLECULAR CLASSIFICATION OF THE FRONTOTEMPORAL DEMENTIAS. A REVIEW OF THE LITERATURE REVISTA DE NEUROLOGIA. 2008 DEC 1; 47 (11): 588-598	2	3	46	75
800	22436 Chatterjee S, Sang TK, Lawless GM, Jackson GR Dissociation of tau toxicity and phosphorylation: role of GSK-3 beta, MARK and Cdk5 in a Drosophila model HUMAN MOLECULAR GENETICS. 2009 JAN 1; 18 (1): 164-177	16	18	46	68

Date / Author / Journal

LCS

GCS

LCR

701

15791 Neumann M, Mittelbronn M, Simon P, Vanmassenhove B, de Silva R, et al.

A New family with frontotemporal dementia with intronic 10+3 splice site mutation in the tau gene: neuropathology and molecular effects

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2005 AUG; 31 (4): 362-373

702

15945 Kaul S, Anantharam V, Kanthasamy A, Kanthasamy AG

Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKC delta and BAD to protect dopaminergic neuronal cells against MPP+- induced apoptotic cell death

MOLECULAR BRAIN RESEARCH. 2005 SEP 13; 139 (1): 137-152

103

703

17182 Avila J

Tau phosphorylation and aggregation in Alzheimer's disease pathology

FEBS LETTERS. 2006 MAY 22; 580 (12): 2922-2927

704

17481 Reddy PH, McWeeney S

Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models

NEUROBIOLOGY OF AGING. 2006 AUG; 27 (8): 1060-1077

162

705

17850 Ozawa T

Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum

ACTA NEUROPATHOLOGICA. 2006 NOV; 112 (5): 531-538

101

706

18317 O'Neill MJ, Messenger MJ, Lakics V, Murray TK, Karran EH, et al.

Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease

PHARMACOLOGY OF NEUROGENESIS AND NEUROENHANCEMENT. 2007; 77: 179-+

243

707

18355 Eriksen JL, Janus CG

Plaques, tangles, and memory loss in mouse models of neurodegeneration

BEHAVIOR GENETICS. 2007 JAN; 37 (1): 79-100

228

708

20020 Frasier M, Frausto S, Lewicki D, Golbe L, Wolozin B

Dissecting the biochemical pathways mediated by genes implicated in Parkinson's disease: Induction of DJ-1 expression in A30P alpha- synuclein mice

ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES. 2008; 57: 97-112

709

21225 Mizuno Y, Hattori N, Kubo SI, Sato S, Nishioka K, et al.

Progress in the pathogenesis and genetics of Parkinson's disease

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2008 JUN 27; 363 (1500): 2215-2227

178

710

21901 Vali S, Chinta SJ, Peng J, Sultana Z, Singh N, et al.

Insights into the effects of alpha-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture data

FREE RADICAL BIOLOGY AND MEDICINE. 2008 NOV 1; 45 (9): 1290-1301

Date / Author / Journal

LCS

GCS

LCR

711

22206 Mandelkow EM, Thies E, Konzack S, Mandelkow E

Tau and Intracellular Transport in Neurons

INTRACELLULAR TRAFFIC AND NEURODEGENERATIVE DISORDERS. 2009; : 59-70

712

22234 Gotz J, Schonrock N, Vissel B, Ittner LM

Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice

JOURNAL OF ALZHEIMERS DISEASE. 2009; 18 (2): 243-251

713

22745 Wolfe MS

Tau Mutations in Neurodegenerative Diseases

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAR 6; 284 (10): 6021-6025

714

23111 Ubhi K, Rockenstein E, Doppler E, Mante M, Adame A, et al.

Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin

ACTA NEUROPATHOLOGICA. 2009 JUN; 117 (6): 699-712

715

23888 Waxman EA, Mazzulli JR, Giasson BI

Characterization of Hydrophobic Residue Requirements for alpha- Synuclein Fibrillization

BIOCHEMISTRY. 2009 OCT 13; 48 (40): 9427-9436

716

24773 Lewis KA, Yaeger A, DeMartino GN, Thomas PJ

Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES. 2010 FEB; 42 (1): 85-95

717

25105 Kim EK, Choi EJ

Pathological roles of MAPK signaling pathways in human diseases

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 APR; 1802 (4): 396-405

176

718

25673 Zuccato C, Valenza M, Cattaneo E

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

PHYSIOLOGICAL REVIEWS. 2010 JUL; 90 (3): 905-981

673

719

25775 Peviani M, Caron I, Pizzasegola C, Gensano F, Tortarolo M, et al.

Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 AUG; 9 (4): 491-503

158

720

25885 Iijima K, Gatt A, Iijima-Ando K

Tau Ser262 phosphorylation is critical for A beta 42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease

HUMAN MOLECULAR GENETICS. 2010 AUG 1; 19 (15): 2947-2957

116

Date / Author / Journal

LCS

GCS

LCR

721

26163 Nyhlen J, Constantinescu R, Zetterberg H

Problems associated with fluid biomarkers for Parkinson's disease

BIOMARKERS IN MEDICINE. 2010 OCT; 4 (5): 671-681

121

722

26305 Roodveldt C, Labrador-Garrido A, Gonzalez-Rey E, Fernandez-Montesinos R, Caro M, et al.

Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants

PLOS ONE. 2010 OCT 26; 5 (10): Art. No. e13481

723

26408 Jucker M

The benefits and limitations of animal models for translational research in neurodegenerative diseases

NATURE MEDICINE. 2010 NOV; 16 (11): 1210-1214

106

724

26880 Jellinger KA, Grazer A, Petrovic K, Ropele S, Alpi G, et al.

Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration?

ACTA NEUROPATHOLOGICA. 2011 FEB; 121 (2): 267-277

725

5226 Tranchant C

Tau proteins and neurodegenerative diseases

M S-MEDECINE SCIENCES. 1997 AUG-SEP; 13 (8-9): 989-997

726

5612 Shea TB, Ekinci FJ

Influence of phospholipids and sequential kinase activities on tau in vitro

MOLECULAR AND CELLULAR MECHANISMS OF NEURONAL PLASTICITY. 1998; 446: 181-201

727

7846 Spillantini MG, Goedert M

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 16-27

103

728

8790 Ksiezak-Reding H, He DK, Gordon-Krajcer W, Kress Y, Lee S, et al.

Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes

CELL MOTILITY AND THE CYTOSKELETON. 2000 NOV; 47 (3): 236-252

729

9393 Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, et al.

Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

BRAIN PATHOLOGY. 2001 APR; 11 (2): 144-158

103

730

10866 Mehta PD, Pirttila T

Biological markers of Alzheimer's disease

DRUG DEVELOPMENT RESEARCH. 2002 JUN; 56 (2): 74-84

115

Date / Author / Journal

LCS

GCS

LCR

731

11783 Kesavapany S, Li BS, Pant HC

Cyclin-dependent kinase 5 in neurofilament function and regulation

NEUROSIGNALS. 2003; 12 (4-5): 252-264

732

12830 Andreasen N, Sjogren M, Blennow K

CSF markers for Alzheimer's disease: Total Tau, phospho-tau and A beta 42

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2003 OCT; 4 (4): 147-155

733

12851 Hegde ML, Rao KSJ

Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2003 OCT 15; 418 (2): 169-178

734

13497 Krishnamurthy PK, Johnson GVW

Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 FEB 27; 279 (9): 7893-7900

735

14756 Casetta I, Govoni V, Granieri E

Oxidative stress, antioxidants and neurodegenerative diseases

CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (16): 2033-2052

366

736

14817 Liu YY, Yang H

Environmental toxins and alpha-synuclein in Parkinson's disease

MOLECULAR NEUROBIOLOGY. 2005; 31 (1-3): 273-282

737

14850 Pountney DL, Voelcker NH, Gai WP

Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis.

NEUROTOXICITY RESEARCH. 2005; 7 (1-2): 59-67

738

14956 Hyman BT, Augustinack JC, Ingelsson M

Transcriptional and conformational changes of the tau molecule in Alzheimer's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 150-157

739

15086 Newman MB, Misiuta I, Willing AE, Zigova T, Karl RC, et al.

Tumorigenicity issues of embryonic carcinoma-derived stem cells: Relevance to surgical trials using NT2 and hNT neural cells

STEM CELLS AND DEVELOPMENT. 2005 FEB; 14 (1): 29-43

125

740

16067 Utton MA, Noble WJ, Hill JE, Anderton BH, Hanger DP

Molecular motors implicated in the axonal transport of tau and alpha- synuclein

JOURNAL OF CELL SCIENCE. 2005 OCT 15; 118 (20): 4645-4654

Date / Author / Journal

LCS

GCS

LCR

741

16174 Imbimbo BP, Lombard J, Pomara N

Pathophysiology of Alzheimer's disease

NEUROIMAGING CLINICS OF NORTH AMERICA. 2005 NOV; 15 (4): 727-+

258

742

18751 Yu S, Li X, Liu G, Han J, Zhang C, et al.

Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody

NEUROSCIENCE. 2007 MAR 16; 145 (2): 539-555

743

19615 Boxer AL, Boeve BF

Frontotemporal dementia treatment: Current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2007 OCT-DEC; 21 (4): S79-S87

106

744

19663 Monti B, Polazzi E, Batti L, Crochemore C, Virgili M, et al.

Alpha-synuclein protects cerebellar granule neurons against 6- hydroxydopamine-induced death

JOURNAL OF NEUROCHEMISTRY. 2007 OCT; 103 (2): 518-530

745

19751 Eckermann K, Mocanu MM, Khlistunova I, Biernat J, Nissen A, et al.

The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 OCT 26; 282 (43): 31755-31765

746

20526 Mondragon-Rodriguez S, Mena R, Binder LI, Smith MA, Perry G, et al.

Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2008 FEB; 34 (1): 62-75

747

20553 Rott R, Szargel R, Haskin J, Shani V, Shainskaya A, et al.

Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells

JOURNAL OF BIOLOGICAL CHEMISTRY. 2008 FEB 8; 283 (6): 3316-3328

748

20630 Jellinger KA, Attems J

Cerebral amyloid angiopathy in Lewy body disease

JOURNAL OF NEURAL TRANSMISSION. 2008 MAR; 115 (3): 473-482

749

21231 Kovacs GG, Pittman A, Revesz T, Luk C, Lees A, et al.

MAPT S305I mutation: implications for argyrophilic grain disease

ACTA NEUROPATHOLOGICA. 2008 JUL; 116 (1): 103-118

750

21469 Deierborg T, Soulet D, Roybon L, Hall V, Brundin P

Emerging restorative treatments for Parkinson's disease

PROGRESS IN NEUROBIOLOGY. 2008 AUG; 85 (4): 407-432

300

Date / Author / Journal

LCS

GCS

LCR

751

21865 Ko LW, Ko HHC, Lin WL, Kulathingal JG, Yen SHC

Aggregates Assembled From Overexpression of Wild-Type alpha-Synuclein are not Toxic to Human Neuronal Cells

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 NOV; 67 (11): 1084-1096

752

21899 Wang IF, Wu LS, Shen CKJ

TDP-43: an emerging new player in neurodegenerative diseases

TRENDS IN MOLECULAR MEDICINE. 2008 NOV; 14 (11): 479-485

753

21929 Nakamura K, Nemani VM, Wallender EK, Kaehlcke K, Ott M, et al.

Optical Reporters for the Conformation of alpha-Synuclein Reveal a Specific Interaction with Mitochondria

JOURNAL OF NEUROSCIENCE. 2008 NOV 19; 28 (47): 12305-12317

754

22409 Han D, Paudel HK

FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract

NEUROCHEMISTRY INTERNATIONAL. 2009 JAN; 54 (1): 14-27

755

22678 Castellani RJ, Zhu XW, Lee HG, Smith MA, Perry G

Molecular Pathogenesis of Alzheimer's Disease: Reductionist versus Expansionist Approaches

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 1386-1406

146

756

22789 Yokota O, Tsuchiya K, Arai T, Yagishita S, Matsubara O, et al.

Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions

ACTA NEUROPATHOLOGICA. 2009 APR; 117 (4): 429-444

757

22827 Vucic S, Kiernan MC

Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis

CURRENT MOLECULAR MEDICINE. 2009 APR; 9 (3): 255-272

292

758

23924 Bulat N, Widmann C

Caspase substrates and neurodegenerative diseases

BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 251-267

205

759

23963 Ardley HC

Ring Finger Ubiquitin Protein Ligases and Their Implication to the Pathogenesis of Human Diseases

CURRENT PHARMACEUTICAL DESIGN. 2009 NOV; 15 (31): 3697-3715

303

760

24321 Shah A, Garzon-Muvdi T, Mahajan R, Duenas VJ, Quinones-Hinojosa A

Animal Models of Neurological Disease

FRONTIERS IN BRAIN REPAIR. 2010; 671: 23-40

132

Date / Author / Journal

LCS

GCS

LCR

761

24466 Fortin DL, Nemani VM, Nakamura K, Edwards RH

The Behavior of alpha-Synuclein in Neurons

MOVEMENT DISORDERS. 2010; 25 (3): S21-S26

762

24628 Arvanitakis Z

Update on Frontotemporal Dementia

NEUROLOGIST. 2010 JAN; 16 (1): 16-22

763

24679 Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, et al.

Increased Expression of alpha-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

NEURON. 2010 JAN 14; 65 (1): 66-79

764

25040 Paleologou KE, Oueslati A, Shakked G, Rospigliosi CC, Kim HY, et al.

Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits alpha-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions

JOURNAL OF NEUROSCIENCE. 2010 MAR 3; 30 (9): 3184-3198

765

26335 Huang QA, Figueiredo-Pereira ME

Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications

APOPTOSIS. 2010 NOV; 15 (11): 1292-1311

217

766

26538 Costa J, Gomes C, de Carvalho M

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 764-778

232

767

3438 SHIN RW, Lee VMY, Trojanowski JQ

ALUMINUM MODIFIES THE PROPERTIES OF ALZHEIMERS-DISEASE PHF-TAU PROTEINS IN-VIVO AND IN-VITRO

JOURNAL OF NEUROSCIENCE. 1994 NOV; 14 (11): 7221-7233

768

8211 Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH

Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3 beta

JOURNAL OF NEUROCHEMISTRY. 2000 APR; 74 (4): 1587-1595

169

769

9567 Sayre LM, Smith MA, Perry G

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

CURRENT MEDICINAL CHEMISTRY. 2001 JUN; 8 (7): 721-738

234

232

770

10300 Spillantini MG, Tofaris GK

Molecular biology of Lewy body formation - alpha-Synudeinopathies

MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE. 2002; 51: 483-489

Date / Author / Journal

LCS

GCS

LCR

771

12350 Davis S, Laroche S

What can rodent models tell us about cognitive decline in Alzheimer's disease?

MOLECULAR NEUROBIOLOGY. 2003 JUN; 27 (3): 249-276

240

772

12983 Necula M, Chirita CN, Kuret J

Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 NOV 21; 278 (47): 46674-46680

773

13455 Baptista MJ, Cookson MR, Miller DW

Parkin and alpha-synuclein: Opponent actions in the pathogenesis of Parkinson's disease

NEUROSCIENTIST. 2004 FEB; 10 (1): 63-72

774

13633 Emadi S, Liu RT, Yuan B, Schulz P, McAllister C, et al.

Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments

BIOCHEMISTRY. 2004 MAR 16; 43 (10): 2871-2878

775

14629 Ko LW, Rush T, Sahara N, Kersh JS, Easson C, et al.

Assembly of filamentous tau aggregates in human neuronal cells

JOURNAL OF ALZHEIMERS DISEASE. 2004 DEC; 6 (6): 605-622

776

14713 Hoyer W, Cherny D, Subramaniam V, Jovin TM

Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro

BIOCHEMISTRY. 2004 DEC 28; 43 (51): 16233-16242

777

14727 Bilen J, Bonini NM

Drosophila as a model for human neurodegenerative disease

ANNUAL REVIEW OF GENETICS. 2005; 39: 153-171

111

106

778

14986 Zhou ZD, Yap BP, Gung AYT, Leong SM, Ang ST, et al.

EXPERIMENTAL CELL RESEARCH. 2005 JAN 15; 312 (2): 156-170

779

15556 Armstrong RA, Lantos PL, Cairns NJ

Overlap between neurodegenerative disorders

NEUROPATHOLOGY. 2005 JUN; 25 (2): 111-124

150

780

15930 Hoffner G, Djian P

Transglutaminase and diseases of the central nervous system

FRONTIERS IN BIOSCIENCE. 2005 SEP 1; 10: 3078-3092

134

Date / Author / Journal

LCS

GCS

LCR

781

16399 Stokin GB, Goldstein LSB

Axonal transport and Alzheimer's disease

ANNUAL REVIEW OF BIOCHEMISTRY. 2006; 75: 607-627

181

782

16804 Yoshida H, Craxton M, Jakes R, Zibaee S, Tavare R, et al.

Synuclein proteins of the pufferfish Fugu rubripes: Sequences and functional characterization

BIOCHEMISTRY. 2006 FEB 28; 45 (8): 2599-2607

783

17015 Saido TC, Iwata N

Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease - Towards presymptomatic diagnosis, prevention and therapy

NEUROSCIENCE RESEARCH. 2006 APR; 54 (4): 235-253

171

784

17039 von Coelln R, Thomas B, Andrabi SA, Lim KL, Savitt JM, et al.

Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy

JOURNAL OF NEUROSCIENCE. 2006 APR 5; 26 (14): 3685-3696

785

17493 Shiarli AM, Jennings R, Shi J, Bailey K, Davidson Y, et al.

Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2006 AUG; 32 (4): 374-387

786

17749 Yoshida H, Goedert M

Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38 delta or JNK2 in the presence of heparin generates the AT100 epitope

JOURNAL OF NEUROCHEMISTRY. 2006 OCT; 99 (1): 154-164

787

18199 de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, et al.

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease

IMAGING AND THE AGING BRAIN. 2007; 1097: 114-145

165

788

19044 Mandemakers W, Morais VA, De Strooper B

A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases

JOURNAL OF CELL SCIENCE. 2007 MAY 15; 120 (10): 1707-1716

151

789

19365 Klein C, Lohmann-Hedrich K

Impact of recent genetic findings in Parkinson's disease

CURRENT OPINION IN NEUROLOGY. 2007 AUG; 20 (4): 453-464

172

790

19437 Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, et al.

Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 AUG 10; 282 (32): 23645-23654

Date / Author / Journal

LCS

GCS

LCR

791

19881 Klein C, Schlossmacher MG

Parkinson disease, 10 years after its genetic revolution - Multiple clues to a complex disorder

NEUROLOGY. 2007 NOV 27; 69 (22): 2093-2104

144

792

20135 Pei JJ, Bjorkdahl C, Zhang HY, Zhou XW, Winblad B

p70 S6 kinase and tau in Alzheimer's disease

JOURNAL OF ALZHEIMERS DISEASE. 2008; 14 (4): 385-392

793

20483 Schindowski K, Belarbi K, Buee L

Neurotrophic factors in Alzheimer's disease: role of axonal transport

GENES BRAIN AND BEHAVIOR. 2008 FEB; 7: 43-56

199

794

20817 Mendez MF, Lauterbach EC, Sampson SM, ANPA Comm Res

An evidence-based review of the psychopathology of frontotemporal dementia: A report of the ANPA Committee on Research

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2008 SPR; 20 (2): 130-149

191

795

20947 Waxman EA, Giasson BI

Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2008 MAY; 67 (5): 402-416

796

21284 Shaikh S, Nicholson LFB

Advanced glycation end products induce in vitro cross-linking of alpha- synuclein and accelerate the process of intracellular inclusion body formation

JOURNAL OF NEUROSCIENCE RESEARCH. 2008 JUL; 86 (9): 2071-2082

797

21524 Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG

Multiple system atrophy: A primary oligodendrogliopathy

ANNALS OF NEUROLOGY. 2008 SEP; 64 (3): 239-246

798

21671 Abdel-Salam OME

Drugs Used to Treat Parkinson's Disease, Present Status and Future Directions

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 OCT; 7 (4): 321-342

331

799

22052 Toribio-Diaz ME, Morera-Guitart J

CLINICAL AND BIOMOLECULAR CLASSIFICATION OF THE FRONTOTEMPORAL DEMENTIAS. A REVIEW OF THE LITERATURE

REVISTA DE NEUROLOGIA. 2008 DEC 1; 47 (11): 588-598

800

22436 Chatterjee S, Sang TK, Lawless GM, Jackson GR

Dissociation of tau toxicity and phosphorylation: role of GSK-3 beta, MARK and Cdk5 in a Drosophila model

HUMAN MOLECULAR GENETICS. 2009 JAN 1; 18 (1): 164-177

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records